Cambridge Investment Research Advisors »

Citius Pharmaceuticals shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Citius Pharmaceuticals (CTXR) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Citius Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Citius Pharmaceuticals held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Citius Pharmaceuticals by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $12k 10k 1.19
2025-06-30 $292k 184k 1.59

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corp Com (MSFT)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Meta Platforms Inc Cl A (META)
Vanguard Index Fds Growth Etf (VUG)
Spdr Series Trust Portfolio S&P500 (SPLG)

View all positions for Cambridge Investment Research Advisors

Top funds holding Citius Pharmaceuticals

Vanguard Group
Geode Capital Management
Citadel Advisors
Susquehanna International
BlackRock
Northern Trust
UBS Group
Goss Wealth Management
State Street Corporation
Two Sigma Investments
Arkadios Wealth Advisors
Jane Street
XTX Topco
Cambridge Investment Research Advisors
Simplex Trading

View all funds holding Citius Pharmaceuticals